Differing Effects on Gall-Bladder Motility of Lanreotide SR and Octreotide LAR for Treatment of Acromegaly

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje.0.1410590
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

A Comparison Between Octreotide-Lar and Lanreotide-Sr in the Chronic Treatment of Acromegaly

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

Gall Stones and Gall Bladder Motility.

Gut
Gastroenterology
1993English

Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening

Endocrine Abstracts
2016English

Lanreotide vs Octreotide LAR for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Observational Time and Motion Analysis

Journal of Oncology Pharmacy Practice
MedicineOncologyPharmacology
2019English

Change in Quality of Life in Patients With Acromegaly After Treatment With Octreotide LAR: First Application of AcroQoL in Korea

BMJ Open
Medicine
2015English

Medical Treatment of Benign Insulinoma Using Octreotide LAR: A Case Report

Endocrine Journal
EndocrinologyMetabolismDiabetes
2007English

Long-Term Treatment of Acromegaly and Gigantism With Octreotide (SMS 201-995)

Folia Endocrinologica Japonica
1992English

Preoperative Octreotide Therapy in Acromegaly: Associations Between Effects on Glucose Homeostasis and Biochemical Cure

Endocrine Abstracts
2014English

Effects of the Long-Acting Somatostatin Analogue Lanreotide Autogel on Glucose Tolerance and Insulin Resistance in Acromegaly

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy